Aphria

$15.94
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.00 (-5.98%) Today
+$0.23 (+1.46%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Aphria and other stocks, options, and ETFs commission-free!

About APHA

Aphria, Inc. engages in the production and supply of medical cannabis. It operates through the following segments: Cannabis Operations, Distribution Operations, and Business Under Development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution Under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company was founded by Cole Cacciavillani and John Cervini in 2013 and is headquartered in Leamington, Canada. The listed name for APHA is Aphria Inc. Common Shares.

CEO
Irwin David Simon
Employees
1,200
Headquarters
Leamington, Ontario
Founded
2011
Market Cap
5.43B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
20.54M
High Today
$17.00
Low Today
$13.78
Open Price
$16.98
Volume
30.47M
52 Week High
$32.29
52 Week Low
$1.95

APHA News

CNBCMar 5

Cannabis stocks slump for second straight week as prospects dim for nationwide legalization

A worker inspects cannabis plants inside the grow room at the Aphria Inc. Diamond facility in Leamington, Ontario, Canada, on Wednesday, Jan. 13, 2021. Tilray I

APHA Earnings

-$0.10
-$0.05
$0.00
$0.05
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Apr 14, Pre-Market

You May Also Like

GL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure